Public Sector Innovation is Complex and Difficult
…
Public sector innovation is a fundamentally difficult issue
…
It has a range of characteristics which mean that it is not an easy thing to
…
https://www.inami.fgov.be/SiteCollectionDocuments/20a_responsabilisation_IPSS_20j_responsabilisering_OISZ_07.pptx
Anticipating & Accepting
Scientific Insights and Practical Lessons from International Research
…
Aligning policy goals and organizational behavior
…
What does not have an effect on felt
…
https://www.inami.fgov.be/SiteCollectionDocuments/20a_responsabilisation_IPSS_20j_responsabilisering_OISZ_09.pptx
Depending on the data processed by the app, the app is classified into one of the following three categories
…
Category 1: the application does not process any personal data as defined
…
https://www.inami.fgov.be/SiteCollectionDocuments/technical_susceptibility_criteria.docx
Discussion document for the multistakeholders meeting on pharmaceuticals ( Meeting DG GROW 12th September 2017
…
Health policies in the EU aim to increase the healthy life expectancy of
…
https://www.inami.fgov.be/SiteCollectionDocuments/innovative_medicines_with_budgetary_limitations.docx
The use of real world data throughout
an innovative medicine’s lifecycle
…
The challenge for health policies is to provide high quality of care for all, within a sustainable health
…
https://www.inami.fgov.be/SiteCollectionDocuments/real_world_data.docx
INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITÉ SERVICE DES SOINS DE SANTÉ Comité d’évaluation des pratiques
…
médicales en matière de médicaments RIJKSINSTITUUT VOOR ZIEKTE
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_litterature_20230525.pdf
https://www.inami.fgov.be/SiteCollectionDocuments/20a_responsabilisation_IPSS_20j_responsabilisering_OISZ_08.pdf
This literature review was performed by vzw Farmaka asbl and was followed-up by a reading committee
…
Hera Decat MD, vzw Farmaka asbl
…
Griet Goesaert MD, vzw Farmaka asbl
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20130516.pdf
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
…
This literature review was performed by vzw Farmaka asbl and was followed-up by a reading committee
…
Hera Decat MD, vzw Farmaka asbl
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20131121.pdf
THE RATIONAL USE OF LIPID LOWERING DRUGS
…
This literature review was performed by vzw Farmaka asbl and was followed-up by a reading committee
…
Hera Decat MD, vzw Farmaka asbl
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20140522.pdf
INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITÉ SERVICE DES SOINS DE SANTÉ Comité d’évaluation des pratiques médicales en matière de médicaments THE RATIONAL USE OF
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20141127.pdf
INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITÉ SERVICE DES SOINS DE SANTÉ Comité d’évaluation des pratiques médicales en matière de médicaments RIJKSINSTITUUT VOOR ZIEKTEEN
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20150528.pdf
Comité voor de evalutie van de
…
THE RATIONAL USE OF DRUGS IN HYPERTENSION
…
This literature review was performed by vzw Farmaka asbl and was followed-up by a reading committee
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20151105.pdf
Comité voor de evalutie van de
…
THE RATIONAL USE OF ANTIBIOTICS IN CHILDREN
…
This literature review was performed by vzw Farmaka asbl and was followed-up by a reading committee
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20160602.pdf
Comité voor de evalutie van de
…
THE RATIONAL USE OF THE GLP-1 RECEPTOR AGONISTS IN TYPE 2 DIABETES
…
This literature review was performed by vzw Farmaka asbl and was supervised by a reading
…
https://www.inami.fgov.be/SiteCollectionDocuments/consensus_literatuur_20161117.pdf